ARCHIVES

Also in this 8-page issue: The Cancer Letter wins two awards for its “authoritative examination” of NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 24 | June 11, 2004

Download PDF Visit The Full Archive

Related Articles

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014

To Improve Clinical Trials Participation, Groups Plan An Awareness Campaign.

October 13, 2000

In Brief: Lenhard Elected President Of ACS; House Science Committee Approves CRADA Bill

November 17, 1995

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997